Abstract
Primary care providers are increasingly involved in the management of patients with mental disorders, particularly as integrated models of care emerge. The recent publication of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) represents a shift in the classification of several mental disorders commonly encountered by primary care providers. With the advent of ICD-10 and the movement toward diagnostic specificity, it is crucial that primary care providers understand the rationale behind these changes. This paper provides an overview of the changes in the classification of mental disorders in DSM-5, a description of how these changes relate to frequently used screening tools in the primary care setting, and a critique of how these changes will affect mental health practice from a primary care perspective.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
World Health Organization. Mental Disorders in Primary Care: a WHO Education Package. Geneva: World Health Organization. 1998.
Ader J, Stille CJ, Keller D, Miller BF, Barr MS, Perrin JM. The medical home and integrated behavioral health: advancing the policy agenda. Pediatrics. 2015;135(5):909–17.
Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatr. 1993;50(2):85–94.
Nemeroff CB, Weinberger D, Rutter M, et al. DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions. BMC medicine. 2013;11:202. This article provides a summary of the major critiques, positive and negative, of the changes in DSM-5 from the point of view of leading international psychiatrists.
Allen F. The new crisis of confidence in psychiatric diagnosis. Ann Intern Med. 2013;159(3):221–2.
Insel T. http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml. Accessed September 26, 2016.
Kupfer DJ, Regier DA. Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5. Am J Psychiatry. 2011;168(7):672–4.
Regier DA, Narrow WE, Kuhl EA, Kupfer DJ. The conceptual development of DSM-V. Am J Psychiatry. 2009;166(6):645–50.
Esterberg ML, Compton MT. The psychosis continuum and categorical versus dimensional diagnostic approaches. Curr Psychiatry Rep. 2009;11(3):179–84.
Lopez MF, Compton WM, Grant BF, Breiling JP. Dimensional approaches in diagnostic classification: a critical appraisal. Int J Methods Psychiatr Res. 2007;16 Suppl 1:S6–7.
McCarron RM. The DSM-5 and the art of medicine: certainly uncertain. Ann Intern Med. 2013;159(5):360–1.
Association AP. Highlights of changes from DSM-VI-TR to DSM-5. In: Publishing AP, ed2013. This article written by the publisher of DSM provides a concise summary of the major changes in the classification of disorders in DSM-5.
Hazen EP, McDougle CJ, Volkmar FR. Changes in the diagnostic criteria for autism in DSM-5: controversies and concerns. J Clin Psychiatry. 2013;74(7):739–40.
Halfon N, Kuo AA. What DSM-5 could mean to children with autism and their families. JAMA pediatrics. 2013;167(7):608–13.
Sansone RA, Forbis JS, Sosa T. Primary care perspectives on treating bipolar disorder: a cross-sectional survey. Prim Care Companion CNS Disord. 2011;13(2):doi:10.4088/PCC.10m01072.
Zimmerman M, Ruggero CJ, Chelminski I, Young D. Is bipolar disorder overdiagnosed? J Clin Psychiatry. 2008;69(6):935–40.
Angst J. Bipolar disorders in DSM-5: strengths, problems and perspectives. Int J Bipolar Disord. 2013;1:12.
Cerimele JM, Chwastiak LA, Dodson S, Katon WJ. The prevalence of bipolar disorder in primary care patients with depression or other psychiatric complaints: a systematic review. Psychosomatics. 2013;54(6):515–24.
Baldessarini RJ, Faedda GL, Offidani E, et al. Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. J Affect Disord. 2013;148(1):129–35.
Tondo L, Vazquez G, Baldessarini RJ. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr Scand. 2010;121(6):404–14.
Mixed Features Specifiers American Psychiatric Association; 2013. http://www.dsm5.org/Documents/Mixed%20Features%20Specifier%20Fact%20Sheet.pdf. Accessed November 18, 2015
Hu J, Mansur R, McIntyre RS. Mixed specifier for bipolar mania and depression: highlights of DSM-5 changes and implications for diagnosis and treatment in primary care. The Primary Care Companion for CNS Disorders. 2014;16(2):PCC.13r01599.
Force USPST. Screening for depression in adults: U.S. preventive services task force recommendation statement. Ann Intern Med. 2009;151(11):784–92.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.
Kenneth S, Kendler MD, John Myers MS, Sidney Zisook MD. Does Bereavement-Related Major Depression Differ From Major Depression Associated With Other Stressful Life Events? Am J Psychiatry. 2008;165(11):1449–55.
Spitzer RL, Wakefield JC. DSM-IV diagnostic criterion for clinical significance: does it help solve the false positives problem? Am J Psychiatry. 1999;156(12):1856–64.
Wakefield JC, Schmitz MF, Baer JC. Does the DSM-IV clinical significance criterion for major depression reduce false positives? Evidence from the National Comorbidity Survey Replication. Am J Psychiatry. 2010;167(3):298–304.
Hofler M, Wittche HU. Why do primary care doctors diagnose depression when diagnostic criteria are not met? Int J Method Psychiatr Res. 2000;9:110–20.
Biggs WS, Demuth RH. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician. 2011;84(8):918–24.
Badour CL, Resnick HS, Kilpatrick DG. Associations Between Specific Negative Emotions and DSM-5 PTSD Among a National Sample of Interpersonal Trauma Survivors. J Interpers Violence. 2015. Epub ahead of print.
Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med. 2006;166(17):1855–62.
Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD Checklist for DSM-5 (PCL-5). Boston, MA: National Center for PTSD; 2013.
Spoont MR, Williams Jr JW, Kehle-Forbes S, Nieuwsma JA, Mann-Wrobel MC, Gross R. Does this patient have posttraumatic stress disorder?: rational clinical examination systematic review. JAMA. 2015;314(5):501–10.
Liebschutz J, Saitz R, Brower V, et al. PTSD in urban primary care: high prevalence and low physician recognition. J Gen Intern Med. 2007;22(6):719–26.
Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res. 2003;12(1):34–43.
Dimsdale JE, Creed F, Escobar J, et al. Somatic symptom disorder: an important change in DSM. J Psychosom Res. 2013;75(3):223–8. This article provides an overview of implications of the replacement of the somatoform disorders cluster with somatic symptom disorder and illness anxiety disorder.
Aragona M. Epistemological reflections about the crisis of the DSM-5 and the revolutionary potential of the RDoC project. Dial Phil Ment Neuro Sci. 2014;7:11–20.
Cosgrove L, Krimsky S. A comparison of DSM-IV and DSM-5 panel members' financial associations with industry: a pernicious problem persists. PLoS Med. 2012;9(3), e1001190.
Charney DS, Barlow DH, Botteron K, et al. Neuroscience research agenda to guide development of a pathophysiologically based classification system. In: Kupfer DJ, First MB, Regier DA, editors. A Research Agenda for DSM-V. Washington, D.C.: American Psychiatric Association; 2002. p. 31–83.
insel T. Director's Blog: Transforming Diagnosis 2013; http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml. Accessed September 30, 2015
Insel TR, Lieberman JA. DSM-5 and RDoC: shared interests. 13 May 2013. http://www.nimh.nih.gov/news/science-news/2013/dsm-5-and-rdoc-shared-interests.shtml (accessed 27 Jun 2013). Accessed September 24, 2015.
Frances A. The new somatic symptom disorder in DSM-5 risks mislabeling many people as mentally ill. Bmj. 2013;346:f1580.
Frances A. Saving normal: an insider’s revolt against out-of-control psychiatric diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life. New York: HarperCollins Publishers; 2013.
Batstra L, Frances A. Diagnostic inflation: causes and a suggested cure. J Nerv Ment Dis. 2012;200(6):474–9. Co-authored by the chair of the DSM-IV writing committee, provides a summary of the critique that DSM-5 fosters overdiagnosis of mental disorders.
Olfson M, Blanco C, Liu SM, Wang S, Correll CU. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatr. 2012;69(12):1247–56.
Hampton LM, Daubresse M, Chang HY, Alexander GC, Budnitz DS. Emergency department visits by adults for psychiatric medication adverse events. JAMA psychiatry. 2014;71(9):1006–14.
Pincus HA, Davis WW, McQueen LE. Subthreshold' mental disorders. A review and synthesis of studies on minor depression and other 'brand names. Br J Psychiatry. 1999;174:288–96.
Manaker S. Time to Get Off the Diagnosis Dime Onto the 10th Revision of the International Classification of Diseases. Ann Intern Med. 2015;163(7):557–8.
Crowley RA, Kirschner N, Health, Public Policy Committee of the American College of P. The integration of care for mental health, substance abuse, and other behavioral health conditions into primary care: executive summary of an American College of Physicians Position Paper. Ann Intern Med. 2015;163(4):298–9. Sponsored by the American College of Physicians, this position paper provides a passionate, evidence-based call-to-action for increased integration of mental health services into primary care.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Ian M. Kronish and Nathalie Moise declare that they have no conflict of interest.
Ravi N. Shah is a Board of Trustees member of the American Psychiatric Association (APA) which publishes DSM-5. Dr. Shah is not financially compensated by the APA.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Psychiatry in Primary Care
Rights and permissions
About this article
Cite this article
Kronish, I.M., Shah, R.N. & Moise, N. What Should Primary Care Providers Know About the Changes in DSM-5?. Curr Psychiatry Rep 18, 30 (2016). https://doi.org/10.1007/s11920-016-0666-5
Published:
DOI: https://doi.org/10.1007/s11920-016-0666-5